A phosphorylated derivative of streptomycin accumulated in cultures of Streptomyces griseus ATCC 12475 and SC2376 grown on complex media containing an excess of inorganic phosphate (0.01 M). This compound did not accumulate significantly in the absence of added inorganic phosphate. The phosphorylated derivative did not inhibit growth of Bacillus subtilis or support growth of a streptomycindependent strain of Escherichia coli; however, incubation of the derivative with alkaline phosphatase gave a compound which was active with both systems. In the phosphorylated derivative, phosphate is esterified with an -OH group of the streptidine moiety of streptomycin. It is suggested that the phosphoryl group is introduced during biosynthesis of the streptidine moiety of streptomycin or by the action of streptomycin kinase on preformed streptomycin (or both), and subsequent dephosphorylation by streptomycin-phosphate phosphatase is inhibited by high concentrations of inorganic phosphate. A column chromatographic procedure for separation of streptidine-phosphate, streptomycin-phosphate, and streptomycin is described.
A phosphorylated derivative of streptomycin accumulated in cultures of Streptomyces griseus ATCC 12475 and SC2376 grown on complex media containing an excess of inorganic phosphate (0.01 M). This compound did not accumulate significantly in the absence of added inorganic phosphate. The phosphorylated derivative did not inhibit growth of Bacillus subtilis or support growth of a streptomycindependent strain of Escherichia coli; however, incubation of the derivative with alkaline phosphatase gave a compound which was active with both systems. In the phosphorylated derivative, phosphate is esterified with an -OH group of the streptidine moiety of streptomycin. It is suggested that the phosphoryl group is introduced during biosynthesis of the streptidine moiety of streptomycin or by the action of streptomycin kinase on preformed streptomycin (or both), and subsequent dephosphorylation by streptomycin-phosphate phosphatase is inhibited by high concentrations of inorganic phosphate. A column chromatographic procedure for separation of streptidine-phosphate, streptomycin-phosphate, and streptomycin is described.
We recently reported that mycelia of streptomycin-producing strains of Streptomyces contain a highly active streptomycin kinase (3). Enzyme specificity studies indicated that the phosphate group is probably esterified at the 6-position of the streptidine moiety of streptomycin ( Fig. 1 ; see references 3, 9, 11). It was suggested that streptomycin-producing bacteria might utilize this kinase to maintain streptomycin, a potent inhibitor of protein biosynthesis, in a nontoxic form. Indeed, it appeared reasonable that, in at least one phase of the life cycle, streptomycin and streptomycin-P might represent active and inactive forms of a normal physiological regulator of protein synthesis (3, 12) , as indicated in reactions 1 and 2. Preliminary studies with a partially purified enzyme preparation showed that streptomycin-P phosphatase is inhibited significantly (87%) by 17 mm inorganic phosphate. The question then arose whether the presence of a high concentration of inorganic phosphate during production of streptomycin might lead to an accumulation of streptomycin-P as a result of an inhibition of reaction 2. In this paper, we show that a high concentration of inorganic phosphate does indeed lead to an accumulation of streptomycin-P in the culture medium. Bioassays. At the indicated times, cultures of S. griseus were centrifuged, and the supernatant liquids were stored at -20 C prior to assay. Streptomycin content was assayed by spotting 2 ,uliters of supernatant liquid on a 6-mm filter paper disc, drying at 37 C for 30 min, and placing on a nutrient agar plate shortly after surface seeding with spores of Bacillus subtilis ATCC 6633. After incubation at 37 C for 12 to 24 hr, diameters of inhibition zones were compared with those of streptomycin standards. Phosphorylated streptomycin was assayed similarly, after prior incubation of 1 ml of supernatant liquid to which 1 drop of toluene was added, for 24 hr at 37 C with 5 sliters of Escherichia coli alkaline phosphatase (type III, Sigma Chemical Co., St. Louis, Mo.), 5 mg per ml; the dialyzed phosphatase solution is conveniently stored at -20 C. Column fractions, with or without pretreatment with alkaline phosphatase, were also tested for the presence of streptomycin by noting whether their addition permitted growth of streptomycin-dependent E. coli ATCC 15745 on nutrient broth.
MATERIALS AND METHODS
Column separation of streptomycin-P. Streptomycin phosphorylated on the streptidine moiety was synthesized enzymatically by incubating the following mixture for 90 min at 37 C: streptomycin sulfate, 50 mg/ml, 0.3 ml; 0.5 M tris(hydroxymethyl)aminomethane-hydrochloride (pH 8.8), 0.5 ml; 0.05 M disodium adenosine triphosphate (pH 6.8), 0.5 ml; 0.05 M MgCl2, 0.5 ml; dialyzed lysozyme extract (11) of S. bikiniensis ATCC 11062, 1.0 ml; water, 2.2 ml. After incubation, the mixture was heated for 3 min at 100 C and centrifuged. The supernatant liquid, containing streptomycin-P and unreacted streptomycin, plus a solution of previously prepared (N'-amidino-14C) streptidine-P were then added to a column (1 by 25 cm) of Biorex 70 carboxylic acid resin, 100 to 200 mesh (BioRad Laboratories, Richmond, Calif.). The column had previously been washed with about one column volume of 1 N NH40H until the effluent was ca. pH 11, and then washed with 0.1 M ammonium formate until the effluent was ca. pH 7.0 to 7.5 (about 300 ml required). Stepwise elution with increasing concentrations of ammonium formate was carried out, with a flow rate of 0.6 ml/min, collecting 3-ml fractions. Tubes were assayed for streptomycin and streptomycin-P by the maltol assay of Boxer et al. (1) . Streptomycin and streptomycin-P were distinguished by paper disc bioassays with B. subtilis, both before and after preincubation with alkaline phosphatase. Streptomycin-P from a culture supernatant liquid, which contained 180 jug of streptomycin-P per ml, was separated on a similar column by adding 15 ml of the supernatant liquid to the column, and washing in succession with 60 ml of 0.1 M ammonium formate and 60 ml of 0.3 M ammonium formate, followed by elution of streptomycin-P with 60 ml of 0.8 M ammonium formate. The eluate was evaporated to dryness in a vacuum desiccator over CaCl2; ammonium centrated H2SO4 in petri plates to which glass wool had been added to increase the surface area.
RESULTS
Kinetics of streptomycin-P accumulation. When S. griseus ATCC 12475 was grown on a glucosesoytone-corn steep solids medium, good production of streptomycin was obtained (Fig. 2) . Preincubation of culture supernatant liquids with alkaline phosphatase prior to bioassay gave a slight increase in antibiotic activity early in the production phase. This increment of activity, subsequently shown to be due to streptomycin-P, disappeared within a few days (Fig. 2) . However, when mycelia were grown on the same medium with potassium phosphate added to a final concentration of 10 mm, accumulation of streptomycin-P was greatly enhanced (Fig. 3) Fig. 2) .
The generality of the phosphate effect was investigated by testing a commercial production strain, S. griseus SC2376 (Squibb). The effect of added phosphate on streptomycin-P accumulation was just as pronounced with this strain (Fig. 4  and 5) .
Specificity of the phosphate effect. Sodium phosphate was as effective as potassium phosphate. Sodium sulfate was inactive.
Column separation of streptomycin-P. A procedure was developed for separating streptidine-P, enzymatically synthesized streptomycin-P, and streptomycin on a Biorex 70 carboxylic acid resin column, with ammonium formate as the eluant. 4 . Production of streptomycin (SM) and streptomycin-P (SM-P) by S. griseus SC2376 grown on control medium (solid curves). Dashed curves show SM and SM-P levels when 10 mm inorganic phosphate (P) was added after 4 days of growth on the control medium.
The results obtained by using a mixture of these compounds are shown in Fig. 6. (N'-amidino-lIC) streptidine-P was eluted first, followed by streptomycin-P. Streptomycin remained on the column, but it could be eluted with 2 M ammonium formate (not shown). Biological activity was obtained in the streptomycin-P peak only after preincubation with alkaline phosphatase.
With this information, streptomycin-P was isolated from a suitable culture broth supernatant liquid by collecting and pooling material eluted from a Biorex 70 column by 0.8 M, but not by 0.3 M, ammonium formate. The separated fraction was shown to contain streptomycin-P, since: (i) it gave a positive maltol reaction, and (ii) only after preincubation with alkaline phosphatase did it inhibit growth of B. subtilis and permit growth of a streptomycin-dependent strain of E. coli. The presumed streptomycin-P was also shown to have an RF on ammoniacal phenol paper chromatograms similar to that of authentic streptomycin-P (3). The compound was located by cutting horizontal strips from the thoroughly dried paper, spotting a solution of alkaline phosphatase on the paper, and bioassaying on an agar plate seeded with B. subtilis spores.
Location of the phosphate group. From the elution behavior from a Biorex 70 column and the RF on ammoniacal phenol paper chromatograms, it was apparent that only one phosphate group was esterified with streptomycin. Results summarized in Table 1 show that the phosphate is esterified with an -OH of the streptidine moiety. This procedure was similar to the radiochemical enzymatic exchange assay employed previously for locating the phosphate group in enzymatically synthesized streptomycin-P (3). Amidinotransferase can catalyze incorporation of label from L-(guanidino-"4C) arginine into streptidine-P, in this case formed by mild acid hydrolysis of streptomycin-P, but not into the intact streptomycin-P molecule or into nonphosphorylated streptidine (3) . The higher value of the nonhydrolyzed control, relative to that described previously (3), presumably reflects streptidine-P formed by hydrolysis of streptomycin-P during the prolonged evaporation of pooled column fractions eluted with 0.8 M ammonium formate.
DISCUSSION
In the two streptomycin-producing strains of S. griseus tested, very little streptomycin-P was formed at any time during growth on a complex production medium. However, addition of 10 mm inorganic phosphate to this medium resulted in a marked accumulation of streptomycin-P (Fig. 2 to 5 ). The effect appeared to be specific for the phosphate anion. When phosphate was added to the culture medium while mycelia were actively producing streptomycin, accumulation of streptomycin-P could be detected within a few hours. Our results are consistent with an in vivo inhibition of streptomycin-P phosphatase (reaction 2) by an excess of inorganic phosphate, as was found to occur in vitro with a partially purified enzyme preparation.
As indicated in Fig. 7 , there are at least two possible origins of the accumulated streptomycin-P. We have previously established (3) that streptomycin-P can be formed by enzymatic phosphorylation of streptomycin (reaction 1); this reaction could occur regardless of whether streptomycin is synthesized by pathway A or by pathway B of Fig. 7 . There is some indirect evidence which suggests that streptomycin-P might be an obligatory intermediate in the biosynthesis of streptomycin (pathway A), with the phosphate group being introduced during biosynthesis of the streptidine moiety (11). Streptidine-P, but no free streptidine, has been detected in mycelia fed myo-(I4C)inositol (11) . Streptomycin kinase phosphorylates streptidine (10) in addition to streptomycin (3), and this enzyme might well act to keep all intermediates in pathway A in a phosphorylated form during streptomycin biosynthesis. Further work on this problem is planned.
Nomi and co-workers (5-7) have previously reported an accumulation of streptomycin-P in their strain of S. griseus grown on a high-glucose medium. We could not detect streptomycin-P accumulation with our strains, one of which is a readily available stock strain (ATCC 12475), when they were grown on Nomi's medium. We believe that our method of stimulating streptomycin-P accumulation is less likely to be strainspecific and thus of more general applicability; this could be significant if streptomycin-P should prove to be a useful antibiotic. Morozowich et al. (4) have recently shown that lincomycin-2-P is an VOL. 10(4, 1970 active antibiotic in vivo, being dephosphorylated by nonspecific phosphatases in the animal. It would therefore appear that phosphorylation might be a generally useful molecular modification for a number of antibiotics. Furthermore, our results suggest that it might be profitable to add alkaline phosphatase during routine screening procedures in the search for new antibiotics. One wonders whether the observation made by many early workers, that high concentrations of inorganic phosphate inhibited streptomycin production (2, 8) , might reflect preferential accumulation of streptomycin-P; addition of alkaline phosphatase prior to bioassay might well have given results similar to those described in this paper.
